Five Stocks To Buy According To Top Biotech-Focused Funds
Biotechnology is a very interesting industry to invest in, but also very complex. If you are looking for stocks that are most likely to see their value...
Posts Tagged ‘Felix Baker’
The Healthcare Gurus at Baker Bros. Advisors Were Buying These Stocks in Q3
Baker Bros. Advisors has arguably been the most successful healthcare-focused hedge fund on the Street in recent years. Founded by brothers Julian Baker...
Incyte Corporation (INCY), Seattle Genetics, Inc. (SGEN) & Two More: Top Healthcare Hedge Fund Loves These Stocks
Baker Bros. Advisors is a fund managed by Julian Baker and Felix Baker that mainly invests in biotechnology companies, and today we are going to take...
Aquinox Pharmaceuticals Inc (AQXP): Baker Bros. Advisors Pushes Stake to Over 45%
A newly-amended 13D filing with the Securities and Exchange Commission revealed that Aquinox Pharmaceuticals Inc (NASDAQ:AQXP) has signed an Underwriting...
Biocryst Pharmaceuticals Inc (BCRX): Baker Bros. Advisors Unloads Nearly 4 Million Shares
Julian Baker and Felix Baker‘s Baker Bros. Advisors recently filed an amended Form 13D with the SEC to report the sale of common shares of Biocryst...
Billionaire Leone Boosts Stake in This REIT, Ubben Sells More Shares of Motorola Solutions Inc. (MSI), Plus Two Other Hot Moves
It is generally believed that individuals seeking to become millionaires (and who isn’t?) need to think and act like millionaires. That’s probably...
Seattle Genetics Inc (SGEN): Baker Bros. Keeps Buying Shares
Seattle Genetics Inc. (NASDAQ:SGEN) is the subject of a new 13D filing issued by Julian Baker and Felix Baker‘s Baker Bros. Advisors. Among other things...
Healthcare-focused Baker Bros. Advisors’ Top Picks: Incyte, Alexion, ACADIA & More
Baker Bros. Advisors is a New York City-based fund launched in 2000 by Julian and Felix Baker. The firm focuses on life science and biotechnology companies...
13D Filing: Baker Bros. Advisors Buys More Shares of Seattle Genetics Inc (SGEN)
Seattle Genetics Inc. (NASDAQ:SGEN) is the subject of a new 13D filing issued by Julian Baker and Felix Baker‘s Baker Bros. Advisors, by far the...
Top 5 Healthcare Bets of World-Class Baker Bros. Advisors
Baker Bros. Advisors is one of the most famous healthcare-focused equity hedge funds in the world today. It was founded in 2000 by brothers Julian Baker...
Elite Hedge Funds Make Bigger Moves Into These 2 Stocks
Neal C. Bradsher‘s Broadwood Capital revealed in a recent Form 4 filing with the SEC that it has purchased an additional 2.43 million shares of...
Baker Bros. Relentlessly Adding Shares Of One Biotech, Going Activist On Another
Julian Baker and Felix Baker’s Baker Bros. Advisors continues to relentlessly add shares to its position in Seattle Genetics, Inc. (NASDAQ:SGEN). In...
Don’t Miss White-Hot Baker Bros.’ New Healthcare Picks
At Insider Monkey, we track over 700 hedge funds and investment companies, which allows us to understand the market sentiment towards any given stock....
Another Score For Baker Bros. As Anacor Pharmaceuticals Inc (ANAC) Soars 65% Premarket On Crisaborole Trial Success
Shares of Anacor Pharmaceuticals Inc (NASDAQ:ANAC) soared to a lofty $140.00 per share pre-market high today, or a whopping 65.47% higher than the stock...
Synageva Biopharma Corp (GEVA) Acquisition Helps Baker Bros. Advisors Top All Others In Q2 Returns
With the rapid pace of M&A happening in the biotechnology sector, Julian Baker and Felix Baker‘s Baker Bros. Advisors is making a habit of hitting...
Baker Bros. Advisors Hits the Jackpot with Pharmacyclics Inc (PCYC) Sale; Incyte Corporation (INCY) Among Fund’s Other Top Picks
Julian Baker and Felix Baker‘s Baker Bros. Advisors’ top pick from the end of 2014 has paid off for the fund in a big way in 2015. AbbVie Inc...
Mirati Therapeutics Inc. (MRTX): Baker Bros. Advisors Increases Stake in Growing Stock
Julian Baker and Felix Baker’s Baker Bros. Advisors recently disclosed an increase of around 929,700 shares to its position in Mirati Therapeutics,...
Tekmira Pharmaceuticals Corporation (TKMR): Falcon Edge Capital Discloses 10% Passive Stake
Another one of the funds we track here at Insider Monkey has made a big move into Tekmira Pharmaceuticals Corporation (NASDAQ:TKMR), as it was revealed...
Tekmira Pharmaceuticals Corporation (TKMR): RA Capital Management Discloses 10% Passive Stake
It was revealed in a filing yesterday with the U.S Securities and Exchange Commission that RA Capital Management has opened a large, passive position...
Bellicum Pharmaceuticals Inc (BLCM): Baker Bros. Discloses 16% Passive Stake
As a new filing with the Securities and Exchange Commission showed, Bellicum Pharmaceuticals Inc (NASDAQ:BLCM) has been added to the equity portfolio...
Vanda Pharmaceuticals Inc (VNDA): Deerfield Management Increases Exposure Following Positive Announcement
James Flynn’s Deerfield Management disclosed an increase in its stake in Vanda Pharmaceuticals Inc (NASDAQ:VNDA) on Friday. After adding more than 1...
Seattle Genetics Inc. (SGEN), Cerus Corporation (CERS): Baker Bros. Advisors’ Latest Moves
Baker Bros. Advisors, the fund managed by Julian and Felix Baker disclosed changes in two of its activist positions last Thursday. The firm continued...
Synergy Pharmaceuticals Inc (SGYP), Proteon Therapeutics Inc (PRTO): James E. Flynn and Peter Kolchinsky Think These Stocks Look Healthy
Synergy Pharmaceuticals Inc (NASDAQ:SGYP) and Proteon Therapeutics Inc (NASDAQ:PRTO) are in the spotlight as James E. Flynn’s Deerfield Management and...
Deerfield Management Ups Stake in Aerie Pharmaceuticals Inc (AERI)
In a new filing with the Securities and Exchange Commission, James E. Flynn of Deerfield Management, has revealed a 6.05% stake in Aerie Pharmaceuticals...
Triumph Group Inc (TGI), Intercept Pharmaceuticals Inc (ICPT), Zynga Inc (ZNGA): Viking Global’s Top 5 Small-Cap Picks
Small-cap picks from individual funds might provide investors with attractive investment options. In this article we will look into Andreas Halvorsen’...
Felix Baker Raises Stake in Synageva BioPharma Corp (GEVA) Through Convention of Options
As a new form 4 filing with the Securities and Exchange Commission showed, Julian and Felix Bakers‘ Baker Bros Advisors, a fund focused on the...
Baker Bros Reveals New Stake in Aquinox Pharmaceuticals (AQXP)
In a new filing with the SEC, Julian Baker and Felix Baker’s Baker Bros. Advisors revealed new stake in Aquinox Pharmaceuticals Inc (NASDAQ:AQXP)....
Baker Bros. Advisors’ Latest Moves Involve Genomic Health, Inc. (GHDX), & Celsus Therapeutics PLC (ADR) (CLSXD)
Julian Baker and Felix Baker’s Baker Bros. Advisors have disclosed in a new filing with the SEC adding approximately 4,100 shares to their stake...
Five Hedge Fund Moves in Healthcare Sector From This Week
The healthcare sector is usually very attractive to investors, since the companies involved in it have a great potential to grow. According to Morningstar...
The Baker Brothers Cut Their Position in Incyte Corporation
Julian and Felix Baker and their hedge fund, Baker Bros. Advisors, reported slicing their exposure at Incyte Corporation (NASDAQ:INCY) to 19.53 million...
Baker Bros. Decreases Exposure at Viropharma
Julian and Felix Baker‘s hedge fund, Baker Bros. Advisors, now holds around 4.4 million shares of Viropharma Inc (NASDAQ:VPHM), a newly amended...
Baker Bros. Advisors Sells Some MEI Pharma, Discloses a Massive Stake in Mirati Therapeutics
In a couple 13D filings with the SEC, Julian and Felix Baker‘s Baker Bros. Advisors reported a 19.9% stake in Mirati Therapeutics, Inc. (NASDAQ...
Baker Bros. Buy Some Shares of Mirati Therapeutics
Baker Bros., Mirati Therapeutics: In a new form 4 from today, Julian and Felix Baker‘s Baker Bros. Advisors reported buying 400,000 shares of Mirati...
Make Insider Trading Work For You — Without Going To Jail
Billionaires go to jail for it. Money managers have fled the country and faked suicides when it’s suggested. Hedge funds have paid billions in fines...
The ‘Smart Money’ Loves The 500% Upside On This Biopharma Stock
Orphan drugs, those treating rare conditions for small segments of the population, do not normally get much attention compared with the likes of a $12...
Is Synageva BioPharma a Buy? Baker Bros. Thinks So
Is Synageva BioPharma a buy? Baker Bros. Advisors, a hedge fund managed by Julian and Felix Baker with a focus on biotechnology, increased its stake...
Biotech-Focused Hedge Fund is Bullish on ChemoCentryx Inc (CCXI)
Tracking the activity of hedge funds via their filings with the Securities and Exchange Commission is particularly crucial, since these filings reveal...
What Hedge Funds Think About Kythera Biopharmaceuticals Inc (KYTH)
To the average investor, there are tons of methods market participants can use to track publicly traded companies. Two of the most useful are hedge fund...
Hedge Fund Bets On Onyx Pharmaceuticals, Inc. (ONXX)
As fast as we can type this, Phill Gross and Robert Atchinson’s hedge fund, Adage Capital Partners, disclosed ownership of about 3.7 million shares...
Do Hedge Funds and Insiders Love Halozyme Therapeutics, Inc. (HALO)?
Is Halozyme Therapeutics, Inc. (NASDAQ:HALO) a good investment? Now, according to many investors, hedge funds are seen as delayed, outdated financial...
Repros Therapeutics Inc (RPRX): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
Is it smart to be bullish on Repros Therapeutics Inc (NASDAQ:RPRX)? To many of your peers, hedge funds are viewed as bloated, outdated financial vehicles...
Is XenoPort, Inc. (XNPT) Going to Burn These Hedge Funds?
Should XenoPort, Inc. (NASDAQ:XNPT) investors track the following data? At the moment, there are plenty of metrics market participants can use to monitor...
What Hedge Funds Think About ArQule, Inc. (ARQL)
Is ArQule, Inc. (NASDAQ:ARQL) a good investment? In the 21st century investor’s toolkit, there are many metrics shareholders can use to monitor stocks...
Hedge Funds Are Selling Threshold Pharmaceuticals, Inc. (THLD)
Is it smart to be bullish on Threshold Pharmaceuticals, Inc. (NASDAQ:THLD)? At the moment, there are tons of methods market participants can use to watch...
InterMune Inc (ITMN): Hedge Funds Aren’t Crazy About It, Insider Sentiment Unchanged
What’s a smart InterMune Inc (NASDAQ:ITMN) investor to do? To many market players, hedge funds are perceived as delayed, old financial tools of...
What Hedge Funds Think About Genomic Health, Inc. (GHDX)
In the 21st century investor’s toolkit, there are plenty of indicators investors can use to monitor stocks. Some of the best are hedge fund and insider...
QLT Inc. (USA) (QLTI): Are Hedge Funds Right About This Stock?
Should investors bullish on QLT Inc. (USA) (NASDAQ:QLTI) consider the following data? In the financial world, there are many indicators shareholders...
Incyte Corporation (INCY): Hedge Funds Are Bullish and Insiders Are Undecided, What Should You Do?
Should investors be bullish on Incyte Corporation (NASDAQ:INCY)? In the 21st century investor’s toolkit, there are many gauges shareholders can use...
Viropharma Inc (VPHM): Are Hedge Funds Right About This Stock?
Is Viropharma Inc (NASDAQ:VPHM) a good investment? If you were to ask many traders, hedge funds are seen as useless, old investment vehicles of an era...
Auxilium Pharmaceuticals, Inc. (AUXL): Are Hedge Funds Right About This Stock?
To many of your fellow readers, hedge funds are assumed to be useless, old investment vehicles of a period lost to current times. Although there are more...
